The WHO presented this Thursday a new fight plan against the pandemic of covid-19 in less developed countries and claimed funds of 23.4 billion dollars in the next twelve months to finance it.
“The ACT accelerator – an association of the world’s leading health agencies – needs $ 23.4 billion to help the countries most at risk to procure and deploy means to fight covid-19 from now until September 2022,” says the WHO statement, which insisted on the fact that this sum is “minuscule” compared to the economic losses caused by the pandemic and the cost of reactivation plans.
“Inequitable access to covid-19 tests, treatments and vaccines prolongs the pandemic worldwide and presents the risk of the emergence of new, more dangerous variants, which could escape the means of fighting the disease “, underlines the text.
The pandemic, which has already left almost five million deaths since it appeared in China at the end of 2019, “is far from over,” explained the director general of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, at a press conference.
“So far only 0.4% of the tests and 0.5% of the vaccines applied worldwide have been carried out in low-income countries, although they represent 9% of the world’s population,” the statement insists. .
“We are at a decisive moment that requires decisive leadership to make the world safer,” said Tedros, who in recent months insisted on multiple occasions that the richest countries should abandon their national selfishness and help the poorest to get vaccines.
The balance of the ACT throttle is modest, especially because of the lack of funding that prevented the Covax device from operating at full capacity. This international mechanism was only able to deliver 425 million doses of the immunizing substance to 144 countries, far from its initial targets.
The WHO argues, however, that the ACT served to cut the price of rapid tests in half by transferring technology and knowledge to poor countries and also to increase access to oxygen cylinders.
The UN agency promised that its new strategy will be more transparent and more focused on the supply of vaccines.
With information from AFP.